Skip to content
OpenCapital
Get started

Seres Therapeutics MCRB Q2 2025 earnings

Reported August 6, 2025 · Before market open

EPS-$2.27Beat by $0.45
Revenue estimate$5.9M
EPS estimate-$2.72

Next report

Aug 5, 2026 (In 1 week)
Revenue estimate$179.0K
EPS estimate-$2.19

Versus estimates

Revenue

Q1 2026$358.0KIn lineQ4 2025$438.0KMiss by $4.9MQ3 2025$351.0KMiss by $7.5M

Diluted EPS

Q1 2026-$2.08Miss by $0.20Q4 2025-$1.89Beat by $0.50Q3 2025$0.94Beat by $0.89
Q2 2025-$2.27Beat by $0.45
Q1 2025-$2.24Miss by $1.57Q4 2024-$0.32Miss by $0.15

Ask the moment Seres Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Seres Therapeutics report Q2 2025 earnings?
Seres Therapeutics (MCRB) reported Q2 2025 earnings on August 6, 2025 before market open.
What were Seres Therapeutics's Q2 2025 revenue and EPS?
Seres Therapeutics reported eps of $-2.27 for Q2 2025.
Did Seres Therapeutics beat estimates in Q2 2025?
EPS beat the consensus estimate of $-2.72 by $0.45.
How did Seres Therapeutics's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 48.4% from $-4.40.
Where can I find Seres Therapeutics's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0000950170-25-103611) directly on SEC EDGAR. The filing index links above go to sec.gov.